Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Sunitinib.php on line 2
Sunitinib
LE WE PMID CA
Sunitinib4136Sunitinib

Bevacizumab ttVEGF

Everolimus

Gastrointestinal stromal cell tumor GIST

Kidney (Neoplasm)

Pazopanib

Pegaptanib

Ranibizumab ttVEGF

Sorafenib

Sunitinib

Temsirolimus

2008  
1
Sunitinib for advanced renal cell cancer.
[19707433] Biologics 2(1): 97-105 (2008)
2007  
2
Sunitinib: a novel tyrosine kinase inhibitor. A brief review of its therapeutic potential in the treatment of renal carcinoma and gastrointestinal stromal tumors (GIST).
[18360643] Ther Clin Risk Manag 3(2): 341-8 (2007)
2010  
3
Bevacizumab, sorafenib tosylate, sunitinib and temsirolimus for renal cell carcinoma: a systematic review and economic evaluation.
[20028613] Health Technol Assess 14(2): 1-184, iii-iv (2010)
2007  
4
A preclinical review of sunitinib, a multitargeted receptor tyrosine kinase inhibitor with anti-angiogenic and antitumour activities.
[17761721] Ann Oncol 18 Suppl 10(-): x3-10 (2007)
2007  
5
Surrogate biomarkers in evaluating response to anti-angiogenic agents: focus on sunitinib.
[17761718] Ann Oncol 18 Suppl 10(-): x11-9 (2007)
2007  
6
Sunitinib: bridging present and future cancer treatment.
[17591828] Ann Oncol 18 Suppl 6(-): vi31-4 (2007)
2008  
7
Sunitinib-induced macrocytosis in patients with metastatic renal cell carcinoma.
[18618496] Cancer 113(6): 1309-14 (2008)
2007  
8
CCR drug updates: sorafenib and sunitinib in renal cell carcinoma.
[17606705] Clin Cancer Res 13(13): 3765-70 (2007)
2007  
9
Approval summary: sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinoma.
[17332278] Clin Cancer Res 13(5): 1367-73 (2007)
2010  
10
Targeted therapy for renal cell cancer: current perspectives.
[21122471] Discov Med 10(54): 394-405 (2010)
2007  
11
Vascular endothelial growth factor: biology and therapeutic applications.
[17537667] Int J Biochem Cell Biol 39(7-8): 1349-57 (2007)
2009  
12
2010  
13
Novel multitargeted anticancer oral therapies: sunitinib and sorafenib as a paradigm.
[21090521] Isr Med Assoc J 12(10): 628-32 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Sunitinib.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Sunitinib.php on line 92